| 摘要 |
<p>Disclosed is a marker group for predicting therapeutic effects on hepatitis C, said marker group comprising a combination of a plurality of markers for predicting therapeutic effects on hepatitis C on the basis of SNPs which makes it possible to achieve more precise prediction results. Further disclosed are probes and primers for the plurality of markers, and a testing method and testing kit for predicting therapeutic effects on hepatitis C which involve said probes and primers. Specifically disclosed is a marker group for predicting therapeutic effects on hepatitis C, which is characterized by including a first marker, which is an oligonucleotide or a polynucleotide including genetic polymorphism rs8099917, and at least one oligonucleotide or polynucleotide including genetic polymorphism rs2076954, rs12907066, rs9528038 or rs341554 as another marker.</p> |
